Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055766
Filing Date
2021-11-09
Accepted
2021-11-09 16:31:13
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cue-10q_20210930.htm   iXBRL 10-Q 1916593
2 EX-10.1 cue-ex101_109.htm EX-10.1 352875
3 EX-10.2 cue-ex102_110.htm EX-10.2 43902
4 EX-31.1 cue-ex311_7.htm EX-31.1 16415
5 EX-31.2 cue-ex312_6.htm EX-31.2 16672
6 EX-32.1 cue-ex321_8.htm EX-32.1 10522
7 GRAPHIC gbbvq33aowdk000001.jpg GRAPHIC 69285
  Complete submission text file 0001564590-21-055766.txt   7589230

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cue-20210930.xsd EX-101.SCH 54276
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cue-20210930_cal.xml EX-101.CAL 40368
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20210930_def.xml EX-101.DEF 190851
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20210930_lab.xml EX-101.LAB 417001
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20210930_pre.xml EX-101.PRE 326607
13 EXTRACTED XBRL INSTANCE DOCUMENT cue-10q_20210930_htm.xml XML 1097163
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 211392716
SIC: 2834 Pharmaceutical Preparations